An ETF Chock Full of Pharma Takeover Candidates

Earlier this week, Israel’s Teva Pharmaceuticals (NasdaqGS: TEVA) said it will pay $40.5 billion for Allergan’s (NYSE: AGN) generic drugs unit, underscoring the notion that the healthcare sector remains white hot when it comes to mergers and acquisitions activity. A broad swath of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.